Acoustic products supplier Risuntek made its trading debut in Shenzhen after raising 416 million yuan ($59 million) in its IPO, while biopharmaceutical firm Wantai BioPharm aims to secure 382 million yuan ($54 million) in Shanghai IPO.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
